Global private equity and venture capital news and research

Mega buyout boosts biotech private equity activity $

17 Feb 2014

The value of private equity, venture capital and development capital investment targeting biotechnology companies started 2014 on an impressive note, leaping to its highest point in the last 12 months.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story.

To access the latest news and PREMIUM stories for FREE download the new AltAssets mobile app from the Googe Play or App Store.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015